Romiplostim and Eltrombopag Beat Rituximab for Secondline Chronic Immune Thrombocytopenia Treatment – ASH Clinical News
Romiplostim and Eltrombopag Beat Rituximab for Secondline Chronic Immune Thrombocytopenia Treatment – ASH Annual Meeting, Bleeding Disorders, On Location – ASH Clinical News